The Cost of a Missed Diagnosis: The Economic Case for Metabolic Assessment of Biopsies

Sucess

We look forward to seeing everyone at the Event!

Testimonials

Dr. Wilson Tsai

Director, Thoracic Program, John Muir Health

“Easy shot with EBUS with obvious confirmation of tool in lesion…. ROSE did not show lymphocytes, but CellTivity did! …”

Dr. Michael Pritchett

Director, Chest Center of the Carolinas at FirstHealth

“This technology may improve diagnostic yield, improve adequacy assessment and allows the proceduralist to process and interpret their own biopsies…”

Dr. Stephen Kovacs

Chief, Division of Pulmonary Medicine at UPMC Hamot

“Utilizing CellTivity during our robotic bronchoscopic cases has been a game changer for diagnosis…”

Dr. Ismael Matus

Director of Interventional Pulmonology at ChristianaCare

"This ultimately empowered the proceduralist with information that made the difference between a diagnostic and a non-diagnostic bronchoscopy."

01 — 00